March, 2006    SMM-015

In Theory

What should pharma marketers do when faced with the task of creating a successful international strategy with a new chemical entity that may not be a totally new, fully differentiated molecule? Clinging to industry ‘best practice’ may be perceived as a route to success; but an open approach to bespoke marketing theory is more likely to help you shine.